For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...

The costs of an intracranial meningioma diagnosis can be substantial. Not only can this diagnosis lead to a lifetime of medical bills and other costs, but it can drastically reduce patients’ quality ...

If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

WASHINGTON (7News) — Millions of women in the United States trust the safety of their birth control, never imagining it could lead to severe health conditions like a brain tumor. Yet, cases across the ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

WASHINGTON — The Clinton Health Access Initiative, working with the Gates Foundation and a host of foreign-aid agencies, including USAID, distributes millions of doses of birth-control injections to ...

When many women turned to Depo-Provera as a convenient birth control option, they had no idea it might carry life-altering risks. After years of injections, some began experiencing troubling symptoms ...

The motion cites 22 cases, most in California, filed against brand manufacturer Pfizer Inc. and authorized generic providers. The motion says most of the plaintiffs will be in Massachusetts or ...

The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...